Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-05-26

FDA Approved: ORACEA — Original Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved ORACEA (doxycycline) under an original NDA for the treatment of inflammatory lesions of rosacea in adults. It uses a 40 mg sub-antimicrobial do…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ORACEA (Doxycycline)

Snippet

ORIG AP for ORACEA (DOXYCYCLINE)